Yahoo
Stockholm - Delayed Quote SEK

Stille AB (STIL.ST)

248.50 -1.50 (-0.60%)
At close: October 30 at 12:59:48 PM GMT+1
Chart Range Bar
Loading chart for STIL.ST
  • Previous Close 250.00
  • Open 250.50
  • Bid 244.50 x --
  • Ask 245.00 x --
  • Day's Range 245.00 - 250.50
  • 52 Week Range 143.00 - 283.00
  • Volume 2,316
  • Avg. Volume 9,393
  • Market Cap (intraday) 2.233B
  • Beta (5Y Monthly) 0.32
  • PE Ratio (TTM) 23.18
  • EPS (TTM) 10.72
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date May 8, 2023
  • 1y Target Est 298.00

Stille AB develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, diathermy, knot-holding, tissue, iris, dura, and vascular forceps under the STILLE, Fehling, S&T, and Surgical Holdings brands. Its Surgical Tables segment provides C-arm tables, which are surgical tables used in advanced imaging, cardiac electrophysiology, cardiovascular and vascular, gastrointestinal and abdominal, interventional radiology, neuro/spine, pain management, and pulmonary under the imagiQ and MedStone brands. The company also offers instrument care education, repair and maintenance, and inspection services. Stille AB was founded in 1841 and is headquartered in Torshälla, Sweden.

www.stille.se

239

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

STIL.ST
26.79%
OMX Stockholm 30 Index (^OMX)
13.47%

1-Year Return

STIL.ST
35.42%
OMX Stockholm 30 Index (^OMX)
17.56%

3-Year Return

STIL.ST
127.98%
OMX Stockholm 30 Index (^OMX)
59.03%

5-Year Return

STIL.ST
70.81%
OMX Stockholm 30 Index (^OMX)
42.80%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 170.6M
Earnings 24.54M
Profit Margin 14.38%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
50M
100M
150M
12.0%
14.0%
16.0%

Analyst Insights

View More

Analyst Price Targets

296.00
298.00 Average
248.50 Current
300.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.53%

  • Return on Assets (ttm)

    6.29%

  • Return on Equity (ttm)

    12.81%

  • Revenue (ttm)

    711.42M

  • Net Income Avi to Common (ttm)

    96.26M

  • Diluted EPS (ttm)

    10.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    170.71M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    19.23M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: